Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 823-833

  Li, Cheng Yang ^a   Deng, Yao Liang ^a   Sun, Bing Hua ^a  

^a Medical University   (China)

Author keywords

Apocynin; Calcium oxalate; Losartan; NADPH oxidase; Nephrolithiasis; Oxidative stress; P47phox; Renin angiotensin system (RAS)

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN II; APOCYNIN; LOSARTAN; MESSENGER RNA; PROTEIN P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM OXALATE STONE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY HOMOGENATE; LIPID PEROXIDATION; MALE; NEPHROLITHIASIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACETOPHENONES; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BIOPSY, NEEDLE; BLOTTING, WESTERN; CALCIUM OXALATE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LOSARTAN; MALE; NADPH OXIDASE; NEPHROLITHIASIS; OXIDATIVE STRESS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINALYSIS;

EID: 77954563420     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9534-0     Document Type: Article

References (41)

1. Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31:927-949. doi: 10.1016/S0889-8529(02)00030-0 (Pubitemid 35403491)
2. Huang H-S, Ma M-C, Chen J, Chen C-F (2002) Changes in the oxidant-antioxidant balance in the kidneys of rats with nephrolithiasis induced by ethylene glycol. J Urol 167:2584-2593. doi:10.1016/S0022-5347(05)65042-2
3. Thamilselvan S, Hackett RL, Khan SR (1997) Lipid per-oxidation in ethylene glycol induced hyperoxaluria and CaOx nephrolithiasis. J Urol 157:1059-1063. doi:10.1016/ S0022-5347(01)65141-3
4. Huang H-S, Ma M-C, Chen C-F, Chen J (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 61:1123-1128. doi: 10.1016/S0090-4295(03)00764-7 (Pubitemid 37510105)
5. Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65-69. doi: 10.1007/s00240-004-0444-4 (Pubitemid 40487196)
6. Chen DH, Kaung HL, Miller CM, Resnick MI, Marengo SR (2004) Microarray analysis of changes in renal phe-notype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94:637-650. doi:10.1111/ j.1464-410X.2004.05016.x
7. Green ML, Freel RW, Hatch M (2005) Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats. Kidney Int 68:2629-2638. doi:10.1111/j.1523-1755.2005.00735.x (Pubitemid 43251009)
8. Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349-357. doi:10.1007/s00240-005-0492-4 (Pubitemid 41752056)
9. Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue anti-oxidant status. BJU Int 96:117-126. doi:10.1111/j.1464-410X.2005.05579.x (Pubitemid 40942881)
10. Umekawa T, Byer K, Uemura H, Khan SR (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870-878. doi:10.1093/ndt/gfh750 (Pubitemid 40704021)
11. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173:271-275
12. Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:230-236. doi:10.1016/ S0022-5347(05)67499-X
13. Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3-9
14. Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35-49. doi:10.1007/s00240-001-0228-z (Pubitemid 36055942)
15. Geiszt M, Kopp JB, Varnai P, Leto TL (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010-8014. doi:10.1073/pnas.13013 5897
16. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK (2002) NAD(P)H oxidase derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899-914. doi:10.1089/152308602762197443
17. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501
18. Babior BM, Lambeth JD, Nauseef W (2002) The neutro-phil NADPH oxidase. Arch Biochem Biophys 397:342-344. doi:10.1006/abbi.2001.2642 (Pubitemid 34852301)
19. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890-1898. doi:10.1111/j.1523-1755.2005.00287.x (Pubitemid 40577724)
20. Paliege A, Parsumathy A, Mizel D, Yang T, Schnermann J, Bachmann S (2006) Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290:R694-R700. doi:10.1152/ ajpregu.00219.2005
21. Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557-568. doi:10.1159/ 000082043
22. Umekawa T, Hatanaka YJ, Kurita T, Khan SR (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635-644. doi:10.1097/01. ASN.0000113321.49771.2D
23. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275-280. doi:10.1016/ S0022-5347(05)66144-7
24. Toblli JE, Ferder L, Stella I, De Cavanagh MVE, Angerosa M, Inserra F (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550-1555. doi:10.1016/S0022-5347(05)64519-3
25. Khand FD, Gordge MP, Robertson WG, Noronha-Dutra AA, Hothersall JS (2002) Mitochondrial superoxide production during oxalate mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339-1350. doi: 10.1016/S0891-5849(02)00846-8 (Pubitemid 34607638)
26. Cao L-C, Honeyman TW, Cooney R, Kennington L, Scheid CR, Jonassen JA (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890-1900. doi:10.1111/j.1523-1755.2004.00963.x (Pubitemid 41094313)
27. Engels F, Renirie BF, Hart BA, Labadie RP, Nijkamp FP (1992) Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett 305:254-256. doi:10.1016/0014-5793(92)80680-F
28. Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283-1291. doi:10.1046/j.1523-1755.2003.00226.x (Pubitemid 37153793)
29. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 61:186-194. doi:10.1046/j.1523-1755.2002.00123.x (Pubitemid 34075146)
30. Morrow JD, Roberts LJ (1997) The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1-21. doi:10.1016/S0163-7827(97)00001-5 (Pubitemid 27387112)
31. Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxyl-L-proline. Kidney Int 165:1173-1181
32. Ueda N, Kaushal GP, Shah SV (2000) Apoptotic mechanisms in acute renal failure. Am J Med 108:403-415. doi:10.1016/S0002-9343(00)00311-9 (Pubitemid 30162959)
33. Gill PS, Wilcox CS (2006) NADPH oxidases in the kidney. Antioxid Redox Signal 8:1597-1607. doi:10.1089/ars. 2006.8.1597
34. Shiose A, Kuroda J, Tsuruya K (2001) A novel superoxide producing NADPH oxidase in kidney. J Biol Chem 276:1417-1423. doi:10.1074/jbc.M007597200 (Pubitemid 32096573)
35. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS (2002) Expression and cellular localization of classic NADPH oxidase sub-units in the spontaneously hypertensive rat kidney. Hypertension 39:269-274. doi:10.1161/hy0202.103264 (Pubitemid 34165227)
36. Li JM, Shah AM (2003) ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephrop-athy. J Am Soc Nephrol 14:S221-S226. doi:10.1097/01. ASN.0000077406.67663.E7
37. Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 39:433-437. doi:10.1161/ hy02t2.102991
38. Lavigne MC, Malech HL, Holland SM, Leto TL (2001) Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 104:79-84. doi:10.1161/hc4001.096828
39. Seikaly MG, Aarnt BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357. doi:10.1172/JCI114846
40. Antus B, Exton MS, Rosivall L (2001) Angiotensin II. A regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 14:25-30
41. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T (2002) Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure. Hypertension 40:834-839. doi:10.1161/01.HYP.0000039506.43589.D5 (Pubitemid 35434903)